Want to see AU:C79 full AI Analyst Report?
Top Page
Chrysos Corp. Ltd.
(Sydney:C79)
Select Model
Select Model
Rating:44Neutral
Price Target:
AU$5.00
▼(-31.79% Downside)
Action:Reiterated
Date:05/22/26
The score is held back primarily by weak profitability and cash flow (negative net margin and negative free cash flow), reinforced by bearish technicals with price below key moving averages and negative MACD. A stable, low-leverage balance sheet and strong revenue growth provide support, but valuation is a major headwind given the very high P/E and no dividend yield provided.
Positive Factors
Exceptional Gross Margin
An almost 100% gross margin indicates the PhotonAssay technology has very low direct incremental costs, giving Chrysos structural gross-profit leverage. As deployments scale, revenue growth can flow quickly to gross profit, supporting sustainable long-term margins if operating expenses are controlled.
Negative Factors
Negative Profitability
Persistent negative margins and a falling EBIT margin mean Chrysos is not yet converting revenue into operating profits. Until operating costs are controlled or revenues scale sufficiently, the company may continue to post losses, limiting retained earnings and investor returns over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Exceptional Gross Margin
An almost 100% gross margin indicates the PhotonAssay technology has very low direct incremental costs, giving Chrysos structural gross-profit leverage. As deployments scale, revenue growth can flow quickly to gross profit, supporting sustainable long-term margins if operating expenses are controlled.
Read all positive factors
Chrysos Corp. Ltd. (C79) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$623.28M
Dividend YieldN/A
Average Volume (3M)347.84K
Price to Earnings (P/E)―
Beta (1Y)1.69
Revenue Growth-86.60%
EPS Growth-2255.56%
CountryAU
Employees207
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)-0.04
Shares Outstanding116,501,300
10 Day Avg. Volume301,690
30 Day Avg. Volume347,840
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)2.73
Price to Sales (P/S)8.20
P/FCF Ratio-9.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.90Price Target Upside21.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.07
Revenue Forecast (FY)AU$114.45M
Chrysos Corp. Ltd. Business Overview & Revenue Model
Company Description
Chrysos Corporation Limited is dedicated to creating and delivering advanced solutions for the mining industry. Established in 2016 and based in Adelaide, Australia, the company's flagship product is PhotonAssay. This innovative technology enables...
How the Company Makes Money
Chrysos makes money primarily by commercializing its PhotonAssay technology via customer deployments of its photon assay units and associated services. Revenue is generated from (i) fees tied to the use of PhotonAssay units (typically structured a...
Chrysos Corp. Ltd. Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
60
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.00K | 66.11M | 45.36M | 26.82M | 571.00K | 47.00K |
| Gross Profit | -60.47M | 66.09M | 34.42M | 25.73M | 29.00K | -6.78M |
| EBITDA | -18.18M | 17.34M | 11.68M | 5.09M | 2.16M | -1.03M |
| Net Income | -4.88M | -8.22M | -704.00K | 443.00K | -3.94M | -3.84M |
Balance Sheet | ||||||
| Total Assets | 286.22M | 264.31M | 243.26M | 163.41M | 144.09M | 29.51M |
| Cash, Cash Equivalents and Short-Term Investments | 21.57M | 21.52M | 61.07M | 53.36M | 92.10M | 5.77M |
| Total Debt | 55.10M | 25.41M | 6.67M | 14.28M | 8.82M | 3.14M |
| Total Liabilities | 87.85M | 66.01M | 44.99M | 39.18M | 21.77M | 15.28M |
| Stockholders Equity | 198.38M | 198.30M | 198.27M | 124.23M | 122.32M | 14.23M |
Cash Flow | ||||||
| Free Cash Flow | -47.62M | -59.89M | -56.23M | -42.61M | -25.67M | -7.46M |
| Operating Cash Flow | 7.19M | 8.83M | 3.63M | 4.65M | 1.41M | 613.00K |
| Investing Cash Flow | -57.21M | -68.72M | -59.86M | -47.26M | -26.98M | -8.07M |
| Financing Cash Flow | 46.23M | 17.28M | 64.30M | 3.54M | 111.52M | -268.00K |
Chrysos Corp. Ltd. Technical Analysis
Negative
7.33
Price Trends
5.95
Negative
6.89
Negative
7.41
Negative
Market Momentum
-0.20
Positive
38.67
Neutral
23.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:C79, the sentiment is Negative. The current price of 7.33 is above the 20-day moving average (MA) of 5.64, above the 50-day MA of 5.95, and below the 200-day MA of 7.41, indicating a bearish trend. The MACD of -0.20 indicates Positive momentum. The RSI at 38.67 is Neutral, neither overbought nor oversold. The STOCH value of 23.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:C79.
Chrysos Corp. Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | AU$411.58M | 33.02 | 4.13% | ― | 4.45% | ― | |
49 Neutral | AU$14.38M | -110.00 | -2.67% | ― | 25.60% | 76.00% | |
48 Neutral | AU$23.75M | -5.15 | -27.05% | ― | 4.41% | 19.30% | |
44 Neutral | AU$623.28M | -126.48 | -2.46% | ― | -86.60% | -2255.56% | |
42 Neutral | AU$22.92M | -5.00 | 190.04% | ― | -42.72% | ― | |
41 Neutral | AU$56.48M | -3.58 | -60.02% | ― | 15.14% | -102.70% |
* Technology Sector Average
AU:C79
Chrysos Corp. Ltd.
5.35
0.12
2.29%
AU:3DP
Pointerra
0.03
-0.03
-54.84%
AU:AMX
Aerometrex Ltd.
0.25
0.05
21.95%
AU:VR1
Vection Technologies Ltd.
0.02
-0.02
-40.00%
AU:1CG
UUV Aquabotix Ltd.
0.01
<0.01
10.00%
AU:NXL
Nuix Ltd.
1.22
-1.20
-49.79%
Chrysos Corp. Ltd. Corporate Events
Chrysos Corrects Director Robert Adamson’s Reported Shareholding
Jul 3, 2026
Chrysos Corporation Limited has disclosed a change in director Robert Adamson’s relevant interests in the company’s securities, primarily reflecting a correction to his previously reported final shareholding. Following the adjustment, ...
Chrysos Chair Sells Shares to Cover Tax Liability, Retains Major Stake
Jul 2, 2026
Chrysos Corporation has disclosed that its chairman, Robert Adamson, sold 529,020 ordinary shares in the company to meet a personal tax liability linked to a previously reported restructuring of his shareholding arrangements. Following the transac...
Yarra Capital Group Builds 5.09% Substantial Stake in Chrysos
Jun 18, 2026
Yarra Capital Management, through a network of associated entities, has emerged as a substantial shareholder in Chrysos Corporation Limited after building a 5.09% stake. The group controls 5,931,961 ordinary fully paid shares, held via custodians ...
Chrysos Seeks ASX Quotation for Additional Ordinary Shares
May 24, 2026
Chrysos Corporation Limited has applied for quotation on the ASX of 12,500 ordinary fully paid shares, expanding the number of its listed securities. The newly quoted shares were issued on 21 May 2026, signalling a modest increase in the company&#...
Chrysos Hits Record Assay Volumes as Lease Deals and Global Deployments Accelerate
May 3, 2026
Chrysos Corporation reported record operational performance, with its PhotonAssay™ fleet processing more than one million samples in both March and April 2026, marking a new utilisation high that supports accelerated average assay charges an...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.